Research ArticleArticle
Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus
Stanley Moore, Hsin-Hsuan Juo, Christoffer T. Nielsen, Helena Tyden, Anders A. Bengtsson and Christian Lood
The Journal of Rheumatology December 2019, jrheum.190875; DOI: https://doi.org/10.3899/jrheum.190875
Stanley Moore
From the Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA; Department of Autoimmunity and Biomarkers, Statens Serum Institut, Copenhagen, Denmark; Division of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. This work was supported by the Lupus Research Alliance (grant number 519414) and the Institute of Translational Health Sciences at the University of Washington. S. Moore, Division of Rheumatology, Department of Medicine, University of Washington; H.H. Juo, MD, Division of Rheumatology, Department of Medicine, University of Washington; C.T. Nielsen, MD, PhD, Department of Autoimmunity and Biomarkers, Statens Serum Institut; H. Tyden, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; A.A. Bengtsson, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; C. Lood, PhD, Division of Rheumatology, Department of Medicine, University of Washington. Address correspondence to C. Lood, University of Washington, Division of Rheumatology, 750 Republican St., Room E-545, Seattle, Washington 98109, USA. E-mail: Loodc@uw.edu. Accepted for publication December 3, 2019.
Hsin-Hsuan Juo
From the Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA; Department of Autoimmunity and Biomarkers, Statens Serum Institut, Copenhagen, Denmark; Division of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. This work was supported by the Lupus Research Alliance (grant number 519414) and the Institute of Translational Health Sciences at the University of Washington. S. Moore, Division of Rheumatology, Department of Medicine, University of Washington; H.H. Juo, MD, Division of Rheumatology, Department of Medicine, University of Washington; C.T. Nielsen, MD, PhD, Department of Autoimmunity and Biomarkers, Statens Serum Institut; H. Tyden, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; A.A. Bengtsson, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; C. Lood, PhD, Division of Rheumatology, Department of Medicine, University of Washington. Address correspondence to C. Lood, University of Washington, Division of Rheumatology, 750 Republican St., Room E-545, Seattle, Washington 98109, USA. E-mail: Loodc@uw.edu. Accepted for publication December 3, 2019.
Christoffer T. Nielsen
From the Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA; Department of Autoimmunity and Biomarkers, Statens Serum Institut, Copenhagen, Denmark; Division of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. This work was supported by the Lupus Research Alliance (grant number 519414) and the Institute of Translational Health Sciences at the University of Washington. S. Moore, Division of Rheumatology, Department of Medicine, University of Washington; H.H. Juo, MD, Division of Rheumatology, Department of Medicine, University of Washington; C.T. Nielsen, MD, PhD, Department of Autoimmunity and Biomarkers, Statens Serum Institut; H. Tyden, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; A.A. Bengtsson, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; C. Lood, PhD, Division of Rheumatology, Department of Medicine, University of Washington. Address correspondence to C. Lood, University of Washington, Division of Rheumatology, 750 Republican St., Room E-545, Seattle, Washington 98109, USA. E-mail: Loodc@uw.edu. Accepted for publication December 3, 2019.
Helena Tyden
From the Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA; Department of Autoimmunity and Biomarkers, Statens Serum Institut, Copenhagen, Denmark; Division of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. This work was supported by the Lupus Research Alliance (grant number 519414) and the Institute of Translational Health Sciences at the University of Washington. S. Moore, Division of Rheumatology, Department of Medicine, University of Washington; H.H. Juo, MD, Division of Rheumatology, Department of Medicine, University of Washington; C.T. Nielsen, MD, PhD, Department of Autoimmunity and Biomarkers, Statens Serum Institut; H. Tyden, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; A.A. Bengtsson, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; C. Lood, PhD, Division of Rheumatology, Department of Medicine, University of Washington. Address correspondence to C. Lood, University of Washington, Division of Rheumatology, 750 Republican St., Room E-545, Seattle, Washington 98109, USA. E-mail: Loodc@uw.edu. Accepted for publication December 3, 2019.
Anders A. Bengtsson
From the Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA; Department of Autoimmunity and Biomarkers, Statens Serum Institut, Copenhagen, Denmark; Division of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. This work was supported by the Lupus Research Alliance (grant number 519414) and the Institute of Translational Health Sciences at the University of Washington. S. Moore, Division of Rheumatology, Department of Medicine, University of Washington; H.H. Juo, MD, Division of Rheumatology, Department of Medicine, University of Washington; C.T. Nielsen, MD, PhD, Department of Autoimmunity and Biomarkers, Statens Serum Institut; H. Tyden, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; A.A. Bengtsson, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; C. Lood, PhD, Division of Rheumatology, Department of Medicine, University of Washington. Address correspondence to C. Lood, University of Washington, Division of Rheumatology, 750 Republican St., Room E-545, Seattle, Washington 98109, USA. E-mail: Loodc@uw.edu. Accepted for publication December 3, 2019.
Christian Lood
From the Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA; Department of Autoimmunity and Biomarkers, Statens Serum Institut, Copenhagen, Denmark; Division of Rheumatology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. This work was supported by the Lupus Research Alliance (grant number 519414) and the Institute of Translational Health Sciences at the University of Washington. S. Moore, Division of Rheumatology, Department of Medicine, University of Washington; H.H. Juo, MD, Division of Rheumatology, Department of Medicine, University of Washington; C.T. Nielsen, MD, PhD, Department of Autoimmunity and Biomarkers, Statens Serum Institut; H. Tyden, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; A.A. Bengtsson, MD, PhD, Division of Rheumatology, Department of Clinical Sciences Lund, Lund University; C. Lood, PhD, Division of Rheumatology, Department of Medicine, University of Washington. Address correspondence to C. Lood, University of Washington, Division of Rheumatology, 750 Republican St., Room E-545, Seattle, Washington 98109, USA. E-mail: Loodc@uw.edu. Accepted for publication December 3, 2019.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus
Stanley Moore, Hsin-Hsuan Juo, Christoffer T. Nielsen, Helena Tyden, Anders A. Bengtsson, Christian Lood
The Journal of Rheumatology Dec 2019, jrheum.190875; DOI: 10.3899/jrheum.190875
Role of Neutrophil Extracellular Traps Regarding Patients at Risk of Increased Disease Activity and Cardiovascular Comorbidity in Systemic Lupus Erythematosus
Stanley Moore, Hsin-Hsuan Juo, Christoffer T. Nielsen, Helena Tyden, Anders A. Bengtsson, Christian Lood
The Journal of Rheumatology Dec 2019, jrheum.190875; DOI: 10.3899/jrheum.190875